Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Approved Contact Lenses (CR-6657)

NCT: NCT07819305 · NOT_YET_RECRUITING

NCT IDNCT07819305
StatusNOT_YET_RECRUITING
Start Date2026-09-10
Completion2026-12-03
SponsorJohnson & Johnson Vision Care, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, multi-site, bilateral, 2-week dispensing, randomized, controlled, single-masked (subjects), 2x2 crossover study to evaluate visual acuity.

Frequently Asked Questions

What is Evaluation of Approved Contact Lenses (CR-6657)?

Evaluation of Approved Contact Lenses (CR-6657) is a clinical trial registered under NCT07819305. Current status: NOT_YET_RECRUITING.

What is the status of NCT07819305?

The current status of NCT07819305 (Evaluation of Approved Contact Lenses (CR-6657)) is: NOT_YET_RECRUITING.

When did Evaluation of Approved Contact Lenses (CR-6657) start?

Evaluation of Approved Contact Lenses (CR-6657) started on 2026-09-10.

Related Devices

K210930ACUVUE® OASYS MAX 1-DAY Contact Lenses (senofilcon A)Johnson & Johnson Vision Care, Inc. K160212ACUVUE (senofilcon C) Soft Contact LensJohnson & Johnson Vision Care, Inc. K180299ACUVUE OASYS (senofilcon A) with Photochromic AdditiveJohnson & Johnson Vision Care, Inc. K200243ACUVUE (senofilcon A) Soft Contact Lens MultifocalJohnson & Johnson Vision Care, Inc. K242393Acuity 181™ (tisilfocon A) and Acuity 181™ (tisilfocon A) with Tangible™ Hydra-PEG® Rigid Gas Permeable Contact LensesAcuity Polymers, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑